telmisartan has been researched along with Kidney Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, T; Kawagoe, Y; Koide, H; Nakamura, T; Node, K; Suzuki, T; Ueda, Y | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 1 |
| Mahmood, I | 1 |
| Chrysant, GS; Chrysant, SG; Desai, A | 1 |
| Böger, RH; Maas, R; Quispe-Bravo, S; Schwedhelm, E; Skamira, C | 1 |
| Brickl, R; Franke, H; Stangier, J; Su, CA | 1 |
| Baumelou, B; Chanard, J; Hannedouche, T | 1 |
1 review(s) available for telmisartan and Kidney Failure
| Article | Year |
|---|---|
Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Heart Failure; Humans; Hypertension; Renal Insufficiency; Stroke; Telmisartan; Treatment Outcome | 2005 |
4 trial(s) available for telmisartan and Kidney Failure
| Article | Year |
|---|---|
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cholesterol; Chronic Disease; Creatinine; Female; Humans; Hypertension; Interleukin-6; Kidney Diseases; Male; Matrix Metalloproteinase 9; Middle Aged; Renal Insufficiency; Telmisartan; Triglycerides | 2008 |
Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states?
Topics: Antihypertensive Agents; Area Under Curve; Benzimidazoles; Benzoates; Blood Specimen Collection; Computer Simulation; Drug Monitoring; Humans; Hydrochlorothiazide; Liver Failure; Models, Biological; Renal Insufficiency; Telmisartan | 2003 |
Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Humans; Kidney; Male; Middle Aged; Protein Binding; Renal Dialysis; Renal Insufficiency; Telmisartan | 2000 |
Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Furosemide; Humans; Hypertension, Renal; Male; Middle Aged; Renal Insufficiency; Telmisartan; Treatment Outcome | 2001 |
3 other study(ies) available for telmisartan and Kidney Failure
| Article | Year |
|---|---|
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Ischemia; Ramipril; Renal Insufficiency; Risk; Stroke; Telmisartan; Treatment Outcome | 2009 |
[Improved protection of heart and kidneys in the hypertensive patient. ACE inhibitor and AT1 blocker combined?].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Hypertrophy, Left Ventricular; Ramipril; Renal Insufficiency; Telmisartan | 2003 |
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzimidazoles; Benzoates; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Endothelium, Vascular; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Oxidative Stress; Randomized Controlled Trials as Topic; Renal Insufficiency; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |